New Market Study Published: Iran Pharmaceuticals & Healthcare Report Q3 2013
We continue to view Iran as a difficult pharmaceutical market. International trade sanctions will continue to have a detrimental impact on the government's revenues, while shortages of medicines are likely to persist. Additionally, runaway inflation will severely erode US dollar values of the country's pharmaceutical market, making it even more unattractive to multinational players, despite the large unmet demand for medicines. In the meantime, despite reports of further development of local pharmaceutical manufacturing capabilities and the focus on research into...
View full press release